[
    {
        "file_name": "ZogenixInc_20190509_10-Q_EX-10.2_11663313_EX-10.2_Distributor Agreement.txt",
        "perturbation": [
            {
                "type": "Misaligned Terminology - In Text Contradiction",
                "original_text": "Subject to the terms and conditions of this Agreement, Zogenix hereby appoints Distributor, and Distributor accepts appointment, as the exclusive distributor (even as to Zogenix) of the Product in the Field in the Territory during the Term, and grants to Distributor the exclusive rights to maintain Regulatory Approval of (while Distributor is the MAH Party), package, promote, market, offer for sale, sell, import and distribute the Product in the Field in the Territory during the Term.",
                "changed_text": "Subject to the terms and conditions of this Agreement, Zogenix hereby appoints Supplier, and Supplier accepts appointment, as the exclusive distributor (even as to Zogenix) of the Product in the Field in the Territory during the Term, and grants to Supplier the exclusive rights to maintain Regulatory Approval of (while Supplier is the MAH Party), package, promote, market, offer for sale, sell, import and distribute the Product in the Field in the Territory during the Term.",
                "explanation": "The term 'Distributor' is replaced with 'Supplier' without defining if they are the same. This introduces ambiguity as it's unclear whether 'Supplier' and 'Distributor' refer to the same entity, potentially leading to confusion regarding rights and obligations.",
                "location": "Section 2.1"
            },
            {
                "type": "Misaligned Terminology - In Text Contradiction",
                "original_text": "Zogenix shall have the right to share any and all information received from Distributor under this Section 4.5, or the Pharmacovigilance Agreement, with Zogenix's Affiliates and Zogenix ex-Territory Distributors. The Pharmacovigilance Agreement shall identify the responsibilities of each Party regarding the information to be exchanged and the timeframes for such exchange, regulatory reporting, literature review, risk management, and labeling.",
                "changed_text": "Zogenix shall have the right to share any and all information received from Client under this Section 4.5, or the Pharmacovigilance Agreement, with Zogenix's Affiliates and Zogenix ex-Territory Distributors. The Pharmacovigilance Agreement shall identify the responsibilities of each Party regarding the information to be exchanged and the timeframes for such exchange, regulatory reporting, literature review, risk management, and labeling.",
                "explanation": "The term 'Distributor' is replaced with 'Client' without defining if they are the same. It creates confusion whether both terms are used for the same party, which will lead to further misunderstanding.",
                "location": "Section 4.5"
            },
            {
                "type": "Misaligned Terminology - In Text Contradiction",
                "original_text": "If the Product Trademarks in existence as of the Effective Date are not eligible for trademark protection or for use in connection with the Product in the Field in the Territory or if the Parties agree that alternative or additional Trademarks may be beneficial, Distributor may investigate appropriate Trademarks for the Product in the Territory.",
                "changed_text": "If the Product Trademarks in existence as of the Effective Date are not eligible for trademark protection or for use in connection with the Product in the Field in the Territory or if the Parties agree that alternative or additional Trademarks may be beneficial, Customer may investigate appropriate Trademarks for the Product in the Territory.",
                "explanation": "The term 'Distributor' is replaced with 'Customer' without defining if they are the same. Since, in business operations both terms describe entirely different actors in the supply chain, that will cause a major contradiction in the enforcement.",
                "location": "Section 9.8(a)"
            }
        ]
    }
]